ArticleIDCases2023

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection.

Jennifer Gallacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.